Alex Zambon

Prof. Alex Zambon

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Developmental Cell
Verified
Journal Article
Closed access
NGNuno Guimarães-Camboa
Nuno Guimarães-Camboa
JSJennifer Stowe
Jennifer Stowe
IAIvy Aneas
Ivy Aneas
NSNoboru Sakabe
Noboru Sakabe
PCPaola Cattaneo
Paola Cattaneo
AZAlex Zambon
Alex Zambon

16 January 2017 in Aging Cell
Verified
Journal Article
Open access
LCLeah Cannon
Leah Cannon
AZAlex Zambon
Alex Zambon
ACAnthony Cammarato
Anthony Cammarato
ZZZhi Zhang
Zhi Zhang
GVGeorg Vogler
Georg Vogler
RBRolf Bodmer
Rolf Bodmer
Summary: Aging causes cardiac dysfunction, often leading to heart failure and death. The molecular basis of age‐associated changes in cardiac structure and function is largely unknown. The fruit fly, Drosophila melanogaster, is well‐suited to investigate the genetics of cardiac aging. Flies age rapidly over the course of weeks, benefit from many tools to easily manipulate their genome, and their heart has significant genetic and phenotypic similarities to the human heart. Here, we performed a cardiac‐specific gene expression study on aging Drosophila and carried out a comparative meta‐analysis with published rodent data. Pathway level transcriptome comparisons suggest that age‐related, extra‐cellular matrix remodeling and alterations in mitochondrial metabolism, protein handling, and contractile functions are conserved between Drosophila and rodent hearts. However, expression of only a few individual genes similarly changed over time between and even within species. We also examined gene expression in single fly hearts and found significant variability as has been reported in rodents. We propose that individuals may arrive at similar cardiac aging phenotypes via dissimilar transcriptional changes, including those in transcription factors and micro‐RNAs. Finally, our data suggest the transcription factor Odd‐skipped, which is essential for normal heart development, is also a crucial regulator of cardiac aging.

8 September 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Demi M. CastellanosDemi M. Castellanos
Demi M. Castellanos
JSJiahong Sun
Jiahong Sun
JYJoshua Yang
Joshua Yang
WOWeijun Ou
Weijun Ou
AZAlex Zambon
Alex Zambon
Rachita K SumbriaRachita K Sumbria
Rachita K Sumbria
Non-invasive brain delivery of neurotherapeutics is challenging due to the blood-brain barrier. The revived interest in transferrin receptor antibodies (TfRMAbs) as brain drug-delivery vectors has revealed the effect of dosing regimen, valency, and affinity on brain uptake, TfR expression, and Fc-effector function side effects. These studies have primarily used monovalent TfRMAbs with a human constant region following acute intravenous dosing in mice. The effects of a high-affinity bivalent TfRMAb with a murine constant region, without a fusion partner, following extravascular dosing in mice are, however, not well characterized. Here we elucidate the plasma pharmacokinetics and safety of a high-affinity bivalent TfRMAb with a murine constant region following acute and chronic subcutaneous dosing in adult C57BL/6J male mice. Mice received a single (acute dosing) 3 mg/kg dose, or were treated for four weeks (chronic dosing). TfRMAb and control IgG1 significantly altered reticulocyte counts following acute and chronic dosing, while other hematologic parameters showed minimal change. Chronic TfRMAb dosing did not alter plasma- and brain-iron measurements, nor brain TfR levels, however, it significantly increased splenic-TfR and -iron. Plasma concentrations of TfRMAb were significantly lower in mice chronically treated with IgG1 or TfRMAb. Overall, no injection related reactions were observed in mice.

19 May 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
Karen OcorrKaren Ocorr
Karen Ocorr
AZAlex Zambon
Alex Zambon
YNYoav Nudell
Yoav Nudell
SPSantiago Pineda
Santiago Pineda
SDSoda Diop
Soda Diop
ETErika Taylor
Erika Taylor
Understanding the cellular-molecular substrates of heart disease is key to the development of cardiac specific therapies and to the prevention of off-target effects by non-cardiac targeted drugs. One of the primary targets for therapeutic intervention has been the human ether a go-go (hERG) K+ channel that, together with the KCNQ channel, controls the rate and efficiency of repolarization in human myocardial cells. Neither of these channels plays a major role in adult mouse heart function; however, we show here that the hERG homolog seizure (sei), along with KCNQ, both contribute significantly to adult heart function as they do in humans. In Drosophila, mutations in or cardiac knockdown of sei channels cause arrhythmias that become progressively more severe with age. Intracellular recordings of semi-intact heart preparations revealed that these perturbations also cause electrical remodeling that is reminiscent of the early afterdepolarizations seen in human myocardial cells defective in these channels. In contrast to KCNQ, however, mutations in sei also cause extensive structural remodeling of the myofibrillar organization, which suggests that hERG channel function has a novel link to sarcomeric and myofibrillar integrity. We conclude that deficiency of ion channels with similar electrical functions in cardiomyocytes can lead to different types or extents of electrical and/or structural remodeling impacting cardiac output. We have used the fruit fly cardiac model to show that seizure, the fly homolog of the human ether a go-go K+ channel hERG, is functional in the fly heart. This channel plays a major role in cardiac repolarization in humans but not in adult rodent hearts. Loss of channel function in the fly causes bradycardia, electrical arrhythmia and altered myofibrillar structure. Gene expression analysis indicates that Wnt signaling is affected and we show a genetic interaction between sei and pygopus, a Wnt pathway component, on heart function.

22 August 2019 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
PDF file
THTom Hsu
Tom Hsu
JMJayapal R. Mallareddy
Jayapal R. Mallareddy
KYKayla Yoshida
Kayla Yoshida
VBVincent Bustamante
Vincent Bustamante
TLTim Lee
Tim Lee
AZAlex Zambon
Alex Zambon
Opioids are powerful analgesics acting via the human μ‐opiate receptor (hMOR). Opioid use is associated with adverse effects such as tolerance, addiction, respiratory depression, and constipation. Two synthetic opioids, AH‐7921 and U‐47700 that were developed in the 1970s but never marketed, have recently appeared on the illegal drug market and in forensic toxicology reports. These agents were initially characterized for their analgesic activity in rodents; however, their pharmacology at hMOR has not been delineated. Thus, we synthesized over 50 chemical analogs based on core AH‐7921 and U‐47700 structures to assess for their ability to couple to Gαi signaling and induce hMOR internalization. For both the AH‐7921 and U‐47700 analogs, the 3,4‐dichlorobenzoyl substituents were the most potent with comparable EC50 values for inhibition of cAMP accumulation; 26.49 ± 11.2 nmol L−1 and 8.8 ± 4.9 nmol L−1, respectively. Despite similar potencies for Gαi coupling, these two compounds had strikingly different hMOR internalization efficacies: U‐47700 (10 μmol L−1) induced ~25% hMOR internalization similar to DAMGO while AH‐7921 (10 μmol L−1) induced ~5% hMOR internalization similar to morphine. In addition, the R, R enantiomer of U‐47700 is significantly more potent than the S, S enantiomer at hMOR. In conclusion, these data suggest that U‐47700 and AH‐7921 analogs have high analgesic potential in humans, but with divergent receptor internalization profiles, suggesting that they may exhibit differences in clinical utility or abuse potential.

1 October 2020 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
AZAlex Zambon
Alex Zambon
THTom Hsu
Tom Hsu
SKSeunghee Erin Kim
Seunghee Erin Kim
MKMiranda Klinck
Miranda Klinck
JSJennifer Stowe
Jennifer Stowe
AHAnna I. Hickerson
Anna I. Hickerson
Much of our understanding of the regulatory mechanisms governing the cell cycle in mammals has relied heavily on methods that measure the aggregate state of a population of cells. While instrumental in shaping our current understanding of cell proliferation, these approaches mask the genetic signatures of rare subpopulations such as quiescent (G0) and very slowly dividing (SD) cells. Results described in this study and those of others using single-cell analysis reveal that even in clonally derived immortalized cancer cells, ∼1–5% of cells can exhibit G0 and SD phenotypes. Therefore to enable the study of these rare cell phenotypes we established an integrated molecular, computational, and imaging approach to track, isolate, and genetically perturb single cells as they proliferate. A genetically encoded cell-cycle reporter (K67p-FUCCI) was used to track single cells as they traversed the cell cycle. A set of R-scripts were written to quantify K67p-FUCCI over time. To enable the further study G0 and SD phenotypes, we retrofitted a live cell imaging system with a micromanipulator to enable single-cell targeting for functional validation studies. Single-cell analysis revealed HT1080 and MCF7 cells had a doubling time of ∼24 and ∼48 h, respectively, with high duration variability in G1 and G2 phases. Direct single-cell microinjection of mRNA encoding (GFP) achieves detectable GFP fluorescence within ∼5 h in both cell types. These findings coupled with the possibility of targeting several hundreds of single cells improves throughput and sensitivity over conventional methods to study rare cell subpopulations.